Researchers Patent Brain Damage Recovery Compound
Research 21 Feb 2012
Researchers at the University of Copenhagen have designed, produced and patented a new chemical compound for the possible treatment of brain damage caused by stroke. The compound binds 1,000 times more effectively to the target protein in the brain than the potential drug currently being tested on stroke victims. The results of biological tests have just been published in the renowned journal PNAS. More than 140,000 people die each year from stroke in the United States. Stroke causes the brain to release large amounts of glutamate, an activating signal compound, all at once. This...
Read more

Abbott Release Statement on AIM-HIGH Study
Final results were presented from the AIM-HIGH study, a National Heart, Lung and Blood Institute (NHLBI) study. The study was designed to test whether raising HDL "good" cholesterol by adding Niaspan to simvastatin would provide an additional 25 percent reduction in cardiovascular outcomes in patients with established cardiovascular...
Industry News

EHRA Urges Physicians to Gain Health Economics Knowledge
Even though the use of device therapies for the treatment of heart failure, heart rhythm disturbances and atrial fibrillation has increased enormously in Europe in recent years, there still remains a fear that economic policy, and not just evidence-based therapeutic benefit, will determine access to treatments, especially at this time of financial...
Association News

Dr. Max Harry Weil, Pioneer in Critical Care, Dies at 84
Dr. Max Harry Weil, called the father of the critical care movement, died of prostate cancer at his home at age 84. The founder of the Weil Institute of Critical Care, he is credited with developing the first ICUs and introducing computerised patient monitors. "The things that we are doing right now are all because of him," said Dr....
Leader Portraits, Management, Research

Researchers Patent Brain Damage Recovery Compound
Researchers at the University of Copenhagen have designed, produced and patented a new chemical compound for the possible treatment of brain damage caused by stroke. The compound binds 1,000 times more effectively to the target protein in the brain than the potential drug currently being tested on stroke victims. The results of biological tests...
Research

CORDIS Launches EU Project Service for Researchers
The European Union has some of the world's best research facilities and most accomplished researchers. Harnessing their full potential will help turn novel ideas into jobs, green growth and social progress. To facilitate this, the European Commission finances, either wholly or partially, a wide range of individual research and technology...
EU News

Finding Could Reduce Antibiotic Use in Critically Ill Patients
Measuring the levels of a natural body chemical may allow doctors to reduce the duration of antibiotic use and improve the health outcomes of critically ill patients. "Infection is a common and expensive complication of critical illness and we're trying to find ways to improve the outcomes of sick, elderly patients and, at the same time...
Management, National, Research

Competition Heats Up: Top Eight Finalists Selected at IT @ Networking Awards 2012
Conference News 19 Jan 2012
IT@2012 logo
Innovative healthcare IT and medical technology solutions are one step closer to winning the coveted IT @ 2012 trophy and cash prize at the IT @ Networking Awards 2012.   Willy Heuschen, Secretary General of the European Association of Hospital Managers officially opened the event, welcoming contestants and delegates. Heuschen highlighted the increasing importance and relevance of healthcare IT and the great opportunity the IT @ Networking Awards is for decision-makers to learn about these solutions; to have access to their developers and users; and to ask questions and judge the...
Read more
Home

Leader Portraits

Dr. Max Harry Weil, Pioneer in Critical Care, Dies at 84
Dr. Max Harry Weil, called the father of the critical care movement, died of prostate cancer at his home at age 84. The founder of the Weil Institute of Critical Care, he is credited with developing the first ICUs and introducing computerised...
Leader Portraits, Management, Research

WHO Director-General names Sir Liam Donaldson envoy for patient safety
WHO Director-General names Sir Liam Donaldson envoy for patient safety WHO Director-General Margaret Chan has named Professor Sir Liam Donaldson as WHO Envoy for Patient Safety. In this role, Sir Liam, who served as England's Chief Medical...
Leader Portraits, Society

ZOLL Medical Receives 2010 North American Market Leadership Award from Frost & Sullivan
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, has received the Frost & Sullivan 2010 Market Leadership Award for the North American external defibrillator market. ZOLL was recognised by Frost &...
Leader Portraits